Calyxt, Inc. (NASDAQ:CLXT – Get Rating) Director Yves J. Ribeill sold 20,000 shares of the stock in a transaction that occurred on Monday, March 21st. The stock was sold at an average price of $1.06, for a total value of $21,200.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, […]
SCYNEXIS, Inc Enters Into Worldwide Agreement With Waterstone Pharmaceutical for the Development and Commercialization of SCY-635 for Viral Diseases mareeg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mareeg.com Daily Mail and Mail on Sunday newspapers.